Literature DB >> 1798031

Hypoxic vasodilatation in isolated, perfused guinea-pig heart: an analysis of the underlying mechanisms.

N von Beckerath1, S Cyrys, A Dischner, J Daut.   

Abstract

1. The mechanisms underlying hypoxic dilatation of coronary arteries were studied in isolated guinea-pig hearts perfused with physiological salt solution at 37 degrees C. The hearts were perfused at a constant rate of 3-10 ml min-1; coronary perfusion pressure (CPP) and isovolumetric left ventricular pressure (LVP) were measured with piezoresistive transducers. 2. Addition of the K+ channel opener cromakalim (500 nM) to the perfusate caused a maximal vasodilatation in beating hearts, i.e. a decrease in CPP of about 50%. Switching from normal perfusate (partial pressure of O2 (PO2), 650-700 mmHg) to hypoxic perfusate (PO2, 9-10 mmHg) caused a similar vasodilatation. Both of these effects were prevented by 2 microM-glibenclamide, a blocker of ATP-sensitive potassium channels. Hypoxic vasodilatation was accompanied by a marked decrease in LVP, which was reduced by 56 +/- 22% (mean +/- S.D.) in the presence of glibenclamide. 3. In hearts arrested by increasing the K+ concentration of the perfusate to 15 mM, the addition of the adenosine-uptake inhibitor dipyridamole evoked a maximal vasodilatation and this was inhibited by 76 +/- 7% in the presence of glibenclamide. 4. The adenosine antagonist 8-phenyltheophylline (8-PT; 5 microM) inhibited the vasodilatation induced by dipyridamole by 88 +/- 10%. In contrast, hypoxic vasodilatation was unaffected by 5 microM 8-PT. This suggests that hypoxic dilatation of coronary arteries is not mediated by release of adenosine from cardiomyocytes. 5. In order to test whether release of endothelium-derived relaxing factor (EDRF) contributed to hypoxic vasodilatation we blocked EDRF synthesis with N omega-nitro-L-arginine (NNA). When applied at a perfusion rate of 10 ml min-1 to arrested hearts, 10 microM-NNA increased CPP by 35% and prolonged the delay between application of hypoxic solution and half-maximal vasodilatation from 52 +/- 9 to 129 +/- 29 s. 6. Under control conditions the relation between perfusion rate and the CPP measured in the steady state was linear. In the presence of 10 microM-NNA coronary resistance was increased more than twofold at low perfusion rates; at perfusion rates between 4 and 10 ml min-1 coronary resistance decreased progressively. This change in the pressure-flow relationship may be responsible for the alterations in the time course of hypoxic vasodilatation induced by NNA. 7. In order to test whether changes in energy metabolism in coronary smooth muscle cells were responsible for hypoxic vasodilatation we blocked glycolysis by replacing the glucose in the perfusate with deoxyglucose (DOG).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1798031      PMCID: PMC1179890          DOI: 10.1113/jphysiol.1991.sp018794

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  31 in total

1.  Transcapillary adenosine transport and interstitial adenosine concentration in guinea pig hearts.

Authors:  R D Wangler; M W Gorman; C Y Wang; D F DeWitt; I S Chan; J B Bassingthwaighte; H V Sparks
Journal:  Am J Physiol       Date:  1989-07

2.  Blood-tissue exchange via transport and transformation by capillary endothelial cells.

Authors:  J B Bassingthwaighte; C Y Wang; I S Chan
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

Review 3.  Metabolic control of coronary blood flow.

Authors:  R A Olsson; R Bünger
Journal:  Prog Cardiovasc Dis       Date:  1987 Mar-Apr       Impact factor: 8.194

Review 4.  Autoregulation of blood flow.

Authors:  P C Johnson
Journal:  Circ Res       Date:  1986-11       Impact factor: 17.367

Review 5.  Myocardial contractile function during ischemia and hypoxia.

Authors:  D G Allen; C H Orchard
Journal:  Circ Res       Date:  1987-02       Impact factor: 17.367

6.  The coronary endothelium: a highly active metabolic barrier for adenosine.

Authors:  S Nees; V Herzog; B F Becker; M Böck; Ch Des Rosiers; E Gerlach
Journal:  Basic Res Cardiol       Date:  1985 Sep-Oct       Impact factor: 17.165

7.  Comparison of the effects of increased myocardial oxygen consumption and adenosine on the coronary microvascular resistance.

Authors:  H Kanatsuka; K G Lamping; C L Eastham; K C Dellsperger; M L Marcus
Journal:  Circ Res       Date:  1989-11       Impact factor: 17.367

8.  Canine coronary vasodepressor responses to hypoxia are abolished by 8-phenyltheophylline.

Authors:  H M Wei; Y H Kang; G F Merrill
Journal:  Am J Physiol       Date:  1989-10

9.  Hypoxia stimulates release of endothelium-derived relaxant factor.

Authors:  U Pohl; R Busse
Journal:  Am J Physiol       Date:  1989-06

10.  Characterization, purification, and affinity labeling of the brain [3H]glibenclamide-binding protein, a putative neuronal ATP-regulated K+ channel.

Authors:  H Bernardi; M Fosset; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more
  28 in total

1.  Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.

Authors:  H M Prior; M S Yates; D J Beech
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation.

Authors:  Matthias Totzeck; Ulrike B Hendgen-Cotta; Peter Luedike; Michael Berenbrink; Johann P Klare; Heinz-Juergen Steinhoff; Dominik Semmler; Sruti Shiva; Daryl Williams; Anja Kipar; Mark T Gladwin; Juergen Schrader; Malte Kelm; Andrew R Cossins; Tienush Rassaf
Journal:  Circulation       Date:  2012-06-09       Impact factor: 29.690

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 5.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

6.  Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia.

Authors:  K Moritani; T Miyazaki; S Miyoshi; M Asanagi; L S Zhao; H Mitamura; S Ogawa
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.

Authors:  A I McCulloch; M D Randall
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  The cardiovascular effects of selective adenosine A1 and A2 receptor agonists in the pithed rat: no role for glibenclamide-sensitive potassium channels.

Authors:  J R Fozard; A M Carruthers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

9.  Effect of hypoxia on force, intracellular pH and Ca2+ concentration in rat cerebral and mesenteric small arteries.

Authors:  C Aalkjaer; J H Lombard
Journal:  J Physiol       Date:  1995-01-15       Impact factor: 5.182

Review 10.  Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injury.

Authors:  David J Lefer; Colin G Nichols; William A Coetzee
Journal:  Trends Cardiovasc Med       Date:  2009-02       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.